Zirconium modified calcium‐silicate‐based nanoceramics: An in vivo evaluation in a rabbit tibial defect model

2018 ◽  
Vol 16 (2) ◽  
pp. 431-437 ◽  
Author(s):  
Ali Doostmohammadi ◽  
Zahra Karimzadeh Esfahani ◽  
Abdolreza Ardeshirylajimi ◽  
Zahra Rahmati Dehkordi
Biomaterials ◽  
2004 ◽  
Vol 25 (20) ◽  
pp. 5037-5044 ◽  
Author(s):  
D. Stubbs ◽  
M. Deakin ◽  
P. Chapman-Sheath ◽  
W. Bruce ◽  
J. Debes ◽  
...  

2019 ◽  
Vol 108 (3) ◽  
pp. 1107-1116 ◽  
Author(s):  
Willams T. Barbosa ◽  
Katilayne V. Almeida ◽  
Gabriel G. Lima ◽  
Miguel A. Rodriguez ◽  
Marcos V. Lia Fook ◽  
...  

2014 ◽  
Vol 11 (6) ◽  
pp. 439-445 ◽  
Author(s):  
Min-Woo Sa ◽  
Sung Eun Kim ◽  
Young-Pil Yun ◽  
Hae-Ryong Song ◽  
Jong Young Kim

Materials ◽  
2018 ◽  
Vol 11 (2) ◽  
pp. 238 ◽  
Author(s):  
Su Park ◽  
Hyo-Jung Lee ◽  
Keun-Suh Kim ◽  
Sang Lee ◽  
Jung-Tae Lee ◽  
...  

Author(s):  
Helio de Jesus Kiyochi Junior ◽  
Aline Gabriela Candido ◽  
Taiana Gabriela Moretti Bonadio ◽  
José Adauto da Cruz ◽  
Mauro Luciano Baesso ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-10 ◽  
Author(s):  
Beom Su Kim ◽  
Feride Shkembi ◽  
Jun Lee

Alendronate (ALN) is a bisphosphonate drug that is widely used for the treatment of osteoporosis. Furthermore, local delivery of ALN has the potential to improve the bone regeneration. This study was designed to investigate an ALN-containing fibrin (fibrin/ALN) gel and evaluate the effect of this gel on both in vitro cellular behavior using human mesenchymal stem cells (hMSCs) and in vivo bone regenerative capacity. Fibrin hydrogels were fabricated using various ALN concentrations (10−7–10−4 M) with fibrin glue and the morphology, mechanical properties, and ALN release kinetics were characterized. Proliferation and osteogenic differentiation of and cytotoxicity in fibrin/ALN gel-embedded hMSCs were examined. In vivo bone formation was evaluated using a rabbit calvarial defect model. The fabricated fibrin/ALN gel was transparent with Young’s modulus of ~13 kPa, and these properties were not affected by ALN concentration. The in vitro studies showed sustained release of ALN from the fibrin gel and revealed that hMSCs cultured in fibrin/ALN gel showed significantly increased proliferation and osteogenic differentiation. In addition, microcomputed tomography and histological analysis revealed that the newly formed bone was significantly enhanced by implantation of fibrin/ALN gel in a calvarial defect model. These results suggest that fibrin/ALN has the potential to improve bone regeneration.


2015 ◽  
Vol 27 (03) ◽  
pp. 1550028 ◽  
Author(s):  
Kam-Kong Chan ◽  
Chia-Hsien Chen ◽  
Lien-Chen Wu ◽  
Yi-Jie Kuo ◽  
Chun-Jen Liao ◽  
...  

Calcium phosphate ceramics, of a similar composition to that of mineral bone, and which possess the properties of bioactivity and osteoconductivity, have been widely used as substitutes for bone graft in orthopedic, plastic and craniofacial surgeries. A synthetic β-tricalcium phosphate, Osteocera™, a recently developed bone graft substitute, has been used in this study. To evaluate the affinity and efficacy of Osteocera™ as bone defect implant, we used a New Zealand white rabbit femur defect model to test the osteoconductivity of this new bone substitute. Alternative commercially available bone substitutes, Triosite® and ProOsteon500, were used as the control materials. These three bone substitutes show good biocompatibility, and no abnormal inflammation either infection was seen at the implantation sites. In the histological and histomorphometric images, newly formed bone grew into the peripheral pores in the bone substitutes. After six months implantation, the volume of bone formation was found to be 20.5 ± 5.2%, 29.8 ± 6.5% and 75.5 ± 4.9% of the potential total cavity offered by ProOsteon500, Triosite® and Osteocera™, respectively. The newly formed bone area within the femur defect section for Osteocera™ was significantly larger than ProOsteon500 and Triosite®. We concluded that Osteocera™ shows better bioresorbability, biocompatibility and osteoconductivity in the rabbit femur defect model.


2015 ◽  
Vol 124 (1) ◽  
pp. 75-81 ◽  
Author(s):  
Kadriye Demirkaya ◽  
Birsen Can Demirdöğen ◽  
Zeynep Öncel Torun ◽  
Onur Erdem ◽  
Serdar Çetinkaya ◽  
...  

2018 ◽  
Vol 2 ◽  
pp. 239784731881949
Author(s):  
Jer Ping Ooi ◽  
Shah Rizal Kasim ◽  
Rumaizi Bin Shaari ◽  
Nor Aini Saidin

Previous studies of the biocompatibility of β-tricalcium phosphate (β-TCP) focused on bulk-sized β-TCP, and little is known about the biocompatibility of nano β-TCP particles (nβ-TCP). The objectives of this study were to synthesize nβ-TCP particles and determine their efficacy in a rabbit tibial defect model. The nβ-TCP particles were first synthesized using a wet chemical precipitation process. The particles were then implanted in the left tibia of New Zealand white rabbits, and the defect site healing was evaluated for a period of 16 weeks using radiography, computed tomography, and histology. Data were compared with those of a sham (empty) control. Results showed that the defect site treated with nβ-TCP particles did not heal completely after 16 weeks, whereas full cortical bone recovery was observed in the sham control group of rabbits. Histopathological examination showed that the nβ-TCP particles caused an excessive and prolonged inflammatory response by the host. The nano-scaled size and biodegradability of the synthesized nβ-TCP particles may have been responsible for this progressive and extended inflammatory response, which delayed the bone healing process. The underlying mechanism for this effect remains unclear and warrants further investigation.


Sign in / Sign up

Export Citation Format

Share Document